Lexeo Therapeutics, Inc. Common Stock Working Capital to Net Assets Ratio
Lexeo Therapeutics, Inc. Common Stock working capital to net assets ratio. Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Working Capital to Net Assets ratio of 86.0% as of June 2026. Working capital of $202.22 Million (current assets of $217.91 Million minus current liabilities of $15.69 Million) is measured against net assets of $235.06 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Lexeo Therapeutics, Inc. Common Stock (LXEO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Lexeo Therapeutics, Inc. Common Stock (2020–2025)
Working capital to net assets ratio of Lexeo Therapeutics, Inc. Common Stock from 2020 to 2025. This chart shows how Lexeo Therapeutics, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 86.0%, reflecting working capital of $202.22 Million against net assets of $235.06 Million USD. See operational self-sufficiency of Lexeo Therapeutics, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Lexeo Therapeutics, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2020–2025)
Lexeo Therapeutics, Inc. Common Stock working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Lexeo Therapeutics, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LXEO total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 69.6% | $171.58 Million | $246.67 Million | $188.39 Million | $16.81 Million | ▼ -18.8 pp |
| 2024 | 88.4% | $103.28 Million | $116.84 Million | $126.12 Million | $22.85 Million | ▼ -5.9 pp |
| 2023 | 94.3% | $107.06 Million | $113.53 Million | $124.29 Million | $17.24 Million | ▲ +152.5 pp |
| 2022 | -58.2% | $65.70 Million | $-112.95 Million | $80.05 Million | $14.35 Million | ▲ +174.3 pp |
| 2021 | -232.4% | $129.24 Million | $-55.60 Million | $136.68 Million | $7.45 Million | ▲ +286.1 pp |
| 2020 | -518.5% | $28.71 Million | $-5.54 Million | $29.41 Million | $697.72K | — |